Rare Disease Genetic Testing Market Growing to Exhibit a Striking Growth with CAGR of 12.26% by 2029, Size, Share, Trends, Competitive Scenario and Industry Growth Analysis

Rare Disease Genetic Testing Market research report displays key data and information about several factors which helps achieve success in the competitive marketplace. Summary of the market is analysed with respect to market players who are mainly customers, businesses or clients. SWOT analysis is the standard, prominent and full-proof method to perform the market research study which is used to formulate this particular Global Rare Disease Genetic Testing Market report. To be ahead of the competition, a systematic idea about the competitive landscape, their product range, their strategies, and future prospects are very important. Market risks and entry barriers makes Healthcare industry aware and help deciding further moves.
Data Bridge Market Research analyses that the rare disease genetic testing market which was USD 785.8 million in 2021, is expected to reach USD 1982.04 million by 2029, at a CAGR of 12.26% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Browse More about Global Rare Disease Genetic Testing Market Research Report at @ https://www.databridgemarketresearch.com/reports/global-rare-disease-genetic-testing-market
Drivers
Genetic testing use in research laboratories
Genetic testing is used in the research laboratories for laboratory test to look for variations in an individual's DNA, typically in the context of medical care, ancestry studies, or forensics. A genetic test's results can be used in a medical setting to confirm a suspected genetic disease. Genetic testing is the use of a laboratory test to examine an individual's DNA for variations, typically performed in the context of ancestry studies, forensics, medical care. These all are the certain factors which propel the growth of market.
Rise in diagnostic testing
Diagnostic testing is used to identify a specific genetic or chromosomal condition. In many cases, genetic testing is used to confirm a diagnosis when a particular condition is suspected based on physical signs and symptoms. Even though uncovering the genetic cause behind a condition may not directly impact treatment options, it will provide physicians and the families with useful information. For instance, physicians can combine genetic testing with existing clinical and biochemical analyses to accurately confirm a disease diagnosis. These are the factors which boost the market's growth.
Some of the major players operating in the Rare Disease Genetic Testing market are:
• Quest Diagnostics Incorporated (U.S.)
• Centogene N.V. (Germany)
• Strand Life Sciences (Bengaluru)
• Ambry Genetics (U.S.)
• PerkinElmer, Inc. (U.S.)
• Macrogen, Inc. (South Korea)
• Baylor Genetics (U.S.)
• HNL Lab Medicine (U.S.)
• Preventiongenetics (U.S.)
• 3billion, Inc. (South Korea)
• Arup Laboratories (U.S.)
• HNL Lab Medicine (U.S.)
• Preventiongenetics (U.S.)
• Invitae Corporation (U.S.)
• Eurofins Scientific (Luxembourg)
• Strand Life Sciences (India)
• Realm IDX, Inc. (China)
• Myriad Genetics, Inc. (U.S.)
• Laboratory Corporation of America Holdings (U.S.)
• Opko Health, Inc. (U.S.)
Recent developments
In December 2020, Cell ID Pte. Ltd., a Singapore-based company that manufactures genetic testing products, will launch the Quiz PCR Biochip, a portable genetic test for COVID-19. This is a portable palm-sized moveable genetic test kit that uses an app to determine whether or not a person has COVID-19. This device also included a QR code for tracking purposes. The device employs pooled screening technology. This is easily portable and can conduct tests at any time
In January 2022, Exact Sciences, a US-based manufacturer of genetic testing tools and a molecular diagnostics company acquired Prevention Genetics for $190 million. Exact Sciences hopes to increase hereditary cancer testing for more patients as a result of this acquisition
Global Rare Disease Genetic Testing Market Scope
The rare disease genetic testing market is segmented on the basis of disease type, technology, speciality, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Disease Type
• Neurological Disorders
• Immunological Disorders
• Hematology Diseases
• Endocrine
• Metabolism Diseases
• Cancer
• Musculoskeletal Disorders
• Cardiovascular Disorders (CVDs)
• Dermatology Disease
• Others
Technology
• Next-Generation Sequencing (NGS)
• Whole Exome Sequencing
• Whole Genome Sequencing
• Array Technology
• PCR-based Testing
• FISH
• Sanger Sequencing
• Karyotyping
Specialty
• Molecular Genetic Tests
• Chromosomal Genetic Tests
• Biochemical Genetic Tests
End Use
• Research Laboratories
• CROs
• Diagnostic Centers
• Hospitals
• Clinics
Table of Contents:
• Introduction
• Market Segmentation
• Executive Summary
• Premium Insights
• Global Rare Disease Genetic Testing Market: Regulations
• Market Overview
• Global Rare Disease Genetic Testing Market, By Type
• Global Rare Disease Genetic Testing Market, By Technology
• Global Rare Disease Genetic Testing Market, By Specialty
• Global Rare Disease Genetic Testing Market, By End User
• Global Rare Disease Genetic Testing Market, By Region
• Global Rare Disease Genetic Testing Market: Company Landscape
• SWOT Analyses
• Company Profile
• Questionnaires
• Related Reports

Browse More Reports of Healthcare Domain by DBMR:

https://dbmrmarkett.blogspot.com/2023/03/middle-east-and-africa-liposuction.html

https://dbmrmarkett.blogspot.com/2023/03/central-america-gastric-cancer.html

https://dbmrmarkett.blogspot.com/2023/03/cervical-cancer-diagnostic-marketsize.html

https://dbmrmarkett.blogspot.com/2023/04/cholesterol-testing-market-overview.html

About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. "Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve."

Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com

This release was published on openPR.